A New Deal for Global Health R&D? The Recommendations of the Consultative Expert Working Group on Research and Development (CEWG)

por Røttingen, John-Arne, Chamas, Claudia
Publicado 2012

Open Source Drug Discovery in Practice: A Case Study

por Årdal, Christine, Røttingen, John-Arne
Publicado 2012

An Open Source Business Model for Malaria

por Årdal, Christine, Røttingen, John-Arne
Publicado 2015

Financing and collaboration on research and development for nodding syndrome

por Årdal, Christine, Røttingen, John-Arne
Publicado 2016

Supra‐SAC: Need and Role for an All‐of‐Government Scientific Advisory Committee

por Røttingen, John‐Arne, Ottersen, Trygve
Publicado 2018

ACT-A: half empty or half full?

por Shisana, Olive, Røttingen, John-Arne
Publicado 2022

Global Challenges: Global Health

por Hoffman, Steven J., Røttingen, John‐Arne
Publicado 2015

Common characteristics of open source software development and applicability for drug discovery: a systematic review

por Årdal, Christine, Alstadsæter, Annette, Røttingen, John-Arne
Publicado 2011

Informing the establishment of the WHO Global Observatory on Health Research and Development: a call for papers

por Adam, Taghreed, Røttingen, John-Arne, Kieny, Marie-Paule
Publicado 2015

The need for global R&D coordination for infectious diseases with epidemic potential

por Kieny, Marie Paule, Rottingen, John-Arne, Farrar, Jeremy
Publicado 2016

Promoting Intersectoral Collaboration Through the Evaluations of Public Health Interventions: Insights From Key Informants in 6 European Countries

por Kriegner, Sabrina, Ottersen, Trygve, Røttingen, John-Arne, Gopinathan, Unni
Publicado 2020

Negotiating public-health intellectual property licensing agreements to increase access to health technologies: an insider’s story

por Gore, Charles, Morin, Sébastien, Røttingen, John-Arne, Kieny, Marie Paule
Publicado 2023

Health policy and systems research: building momentum and community

por Ghaffar, Abdul, Tran, Nhan, Røttingen, John-Arne, Kieny, Marie-Paule
Publicado 2014

An antibiotic’s journey from marketing authorization to use, Norway

por Årdal, Christine, Blix, Hege Salvesen, Plahte, Jens, Røttingen, John-Arne
Publicado 2017

Evaluating official development assistance-funded granting mechanisms for global health and development research that is initiated in high-income countries

por Cassola, Adèle, Baral, Prativa, Røttingen, John-Arne, Hoffman, Steven J.
Publicado 2022

Trends in Health Policy and Systems Research over the Past Decade: Still Too Little Capacity in Low-Income Countries

por Adam, Taghreed, Ahmad, Saad, Bigdeli, Maryam, Ghaffar, Abdul, Røttingen, John-Arne
Publicado 2011

Where is the policy in health policy and systems research agenda?

por Ghaffar, Abdul, Gilson, Lucy, Tomson, Göran, Viergever, Rik, Røttingen, John-Arne
Publicado 2016

R&D for Emerging Infectious Diseases of Epidemic Potential: Sharing Risks and Benefits Through a New Coalition

por Gopinathan, Unni, Peacocke, Elizabeth, Gouglas, Dimitrios, Ottersen, Trygve, Røttingen, John-Arne
Publicado 2020

Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response

por Trøseid, Marius, Diallo, Alpha, Hites, Maya, Røttingen, John-Arne, Yazdanpanah, Yazdan
Publicado 2022

Using European travellers as an early alert to detect emerging pathogens in countries with limited laboratory resources

por Guerin, Philippe J, Grais, Rebecca Freeman, Rottingen, John Arne, Valleron, Alain Jacques
Publicado 2007